ClinicalTrials.Veeva

Menu

Efficacy and Safety of 3% Minoxidil Lotion for Beard Enhancement

M

Mae Fah Luang University Hospital

Status and phase

Completed
Phase 4

Conditions

Beard Enhancement

Treatments

Drug: Placebo
Drug: 3 % Minoxidil lotion

Study type

Interventional

Funder types

Other

Identifiers

NCT02275832
REH-57077

Details and patient eligibility

About

The purpose of this study is to determine efficacy and safety of 3% minoxidil lotion for beard enhancement.

Enrollment

48 patients

Sex

Male

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy male

Exclusion criteria

  • serious underlying diseases.
  • history of beard/ hair treatment before 6 months
  • history of surgery or trauma on beard area.
  • history of minoxidil allergy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

48 participants in 2 patient groups, including a placebo group

Minoxidil
Experimental group
Description:
3% Minoxidil lotion is applied twice daily to the beard.
Treatment:
Drug: 3 % Minoxidil lotion
Placebo
Placebo Comparator group
Description:
Placebo is applied twice daily to beard.
Treatment:
Drug: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems